GILD

Gilead Sciences, Inc. Press Releases

$103.53
*  
0.66
0.63%
Get GILD Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)
2/26/2015 7:05:00 PM - Business Wire


Gilead Announces SVR12 Rates From Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected With HIV
2/26/2015 3:14:00 PM - Business Wire


Gilead Announces Preclinical Data for an Investigational TLR7 Agonist in SIV-Infected, Virally Suppressed Monkeys
2/25/2015 3:27:00 PM - Business Wire


Gilead Sciences to Present at the RBC Capital Markets 2015 Healthcare Conference on Wednesday, February 25
2/24/2015 5:00:00 PM - Business Wire


Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® and Harvoni® in India
2/23/2015 7:00:00 AM - PR Newswire


Gilead Sciences and Beryllium Publish the Structural Basis for HCV RNA Replication in Science
2/12/2015 2:05:00 PM - Business Wire


Gilead Sciences to Present at Two Upcoming Investor Conferences
2/9/2015 5:00:00 PM - Business Wire


Cigna Signs Agreement with Gilead to Improve Affordability of Hepatitis C Treatment for Customers and Clients
2/4/2015 4:03:00 PM - Business Wire


EPAM Systems, Inc. Announces Date for Fourth-Quarter and Full Year 2014 Earnings Release and Conference Call
2/3/2015 4:34:00 PM - GlobeNewswire


Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program
2/3/2015 4:06:00 PM - Business Wire


Gilead Sciences Announces Fourth Quarter and Full Year 2014 Financial Results
2/3/2015 4:05:00 PM - Business Wire


Gilead Announces Executive Promotions
1/28/2015 4:30:00 PM - Business Wire
▲0.41 % Price Change since this news event. The Volume Ratio is 9.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015
1/27/2015 5:00:00 PM - Business Wire
▼-1.94 % Price Change since this news event. The Volume Ratio is 1.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent
1/26/2015 10:58:00 AM - PR Newswire


Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent
1/26/2015 1:00:00 AM - Business Wire
▼-1.77 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year
1/21/2015 1:06:00 PM - PR Newswire


Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13
1/12/2015 5:00:00 PM - Business Wire
▲2.20 % Price Change since this news event. The Volume Ratio is 2.15.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prime Therapeutics Breaks from Competition, Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs
1/12/2015 2:00:00 PM - PR Newswire


Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials
1/9/2015 8:45:00 AM - PR Newswire


BBCN Bancorp to Announce Fourth Quarter 2014 Financial Results on Monday, January 26, 2015
1/8/2015 5:07:00 PM - GlobeNewswire


PW Partners and HG Vora Nominate Six Highly Qualified Directors to Board of Town Sports
1/7/2015 8:45:00 AM - PR Newswire


Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla
1/7/2015 8:45:00 AM - PR Newswire


Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
1/6/2015 8:30:00 AM - Business Wire
▲5.69 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Reveal Earnings Forecast for Apple, Gilead Sciences, Alibaba, Twitter, BlackBerry, and Sirius XM
1/5/2015 8:45:00 AM - PR Newswire


Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment
12/29/2014 8:30:00 AM - Business Wire